Search

Yanmei M Lu

from San Mateo, CA
Age ~59
Get Report
Also known as:
Yan Mei Lu, Yanmei M Lin, Yanmei L Lin, Yan M Lu, Lu Yanmei
Phone and address:
921 Haddock St, San Mateo, CA 94404
Related to:
Roanna LinDavid S Traudt, 55Lori Traudt, 55Li Y Chen, 77Hendratno Tan, 53
Connected to:
Abigail I Lu, 32Aiping Lu, 54Allen C Lu, 46Anjian Lu, 84Anna G Lu, 67Anne B Lu, 72Arnold W Lu, 49Ava Lu, 36Ay K Lu, 54Barbara T Lu, 74

Yanmei Lu Phones & Addresses

  • 921 Haddock St, San Mateo, CA 94404
  • Foster City, CA
  • 1656 Green Springs Ct, Tracy, CA 95377
  • 2310 Carlmont Dr #14, Belmont, CA 94002
  • 1001 Continentals Way #206, Belmont, CA 94002
  • Tampa, FL
  • San Jose, CA

Resumes

Resumes

Yanmei Lu Photo 1

Senior Director, Biomarker And Bioanalytical Sciences

View page
Location:
South San Francisco, CA
Industry:
Biotechnology
Work:
Sangamo Therapeutics
Senior Director, Biomarker and Bioanalytical Sciences
Genentech 2003 - 2018
Scientist
Rigel Pharmaceuticals Inc. 2001 - 2003
Bioinformatics Scientist
Doubletwist 2000 - 2001
Bioinformatics Scientist
Genentech 1996 - 1999
Postdoctoral Research Fellow
Education:
University of South Florida 1991 - 1996
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry
Skills:
Biomarkers
Biotechnology
Drug Discovery
Assay Development
Monoclonal Antibodies
Elisa
Molecular Biology
Antibodies
Cell Culture
Bioinformatics
Cell Biology
Biochemistry
Immunology
Life Sciences
In Vitro
Cell
Lifesciences
Languages:
Mandarin
Yanmei Lu Photo 2

Yanmei Lu

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology

Publications

Us Patents

Nsp Molecules

View page
US Patent:
6891022, May 10, 2005
Filed:
Apr 23, 1999
Appl. No.:
09/298404
Inventors:
Timothy A. Stewart - San Francisco CA, US
Yanmei Lu - Belmont CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K038/00
C07K002/00
C07K004/00
C07K005/00
C07K007/00
US Classification:
5303871, 530300, 530350, 530385, 530386, 5303872, 5303873, 5303877, 5303879, 5303881, 5303882, 5303888, 53038885, 5303911, 5303913, 435325
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to PRO201, PRO308 or PRO309 polypeptides. The invention further relates to compositions and method for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based in part on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targents for the diagnosis and/or treatment (including prevention) of certain tumors (e. g. , cancer) and may act as predictors of the prognosis of tumor treatment.

Multidimensional Biodata Integration And Relationship Inference

View page
US Patent:
7243112, Jul 10, 2007
Filed:
Jun 14, 2002
Appl. No.:
10/480567
Inventors:
Kunbin Qu - Foster City CA, US
Nan Lin - Foster City CA, US
Yanmei Lu - Foster City CA, US
Donald G. Payan - Hillsborough CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G06F 17/30
US Classification:
7071041, 707102, 707103 R, 707 3
Abstract:
This invention provides an advanced platform for the analysis of biological data that emphasizes pathway mapping and relationship inference based upon data acquired from multiple diverse sources. The platform employs a bioinformatic system that integrates data from the diverse sources, connecting related genes and proteins and inferring biological functions in the context of global cellular processes.

Nsp Molecules

View page
US Patent:
20020147322, Oct 10, 2002
Filed:
Aug 15, 2001
Appl. No.:
09/931087
Inventors:
Timothy Stewart - San Francisco CA, US
Yanmei Lu - Foster City CA, US
Assignee:
Genentech, Inc.
International Classification:
C07H021/04
C12Q001/68
G01N033/574
C12P021/02
C12N009/00
C12N005/06
US Classification:
536/023200, 435/006000, 435/007230, 435/325000, 435/320100, 435/069100, 435/183000
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to PRO201, PRO308 or PRO309 polypeptides. The invention further relates to compositions and method for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based in part on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targents for the diagnosis and/or treatment (including prevention) of certain tumors (e.g., cancer) and may act as predictors of the prognosis of tumor treatment.

Nsp Molecules

View page
US Patent:
20030191283, Oct 9, 2003
Filed:
Jan 31, 2002
Appl. No.:
10/062923
Inventors:
Timothy Stewart - San Francisco CA, US
Yanmei Lu - Belmont CA, US
Assignee:
Genentech, Inc.
International Classification:
C12P021/02
C12N005/06
C07H021/04
C07K014/435
US Classification:
530/350000, 435/069100, 435/325000, 435/320100, 536/023500
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to PRO201, PRO308 or PRO309 polypeptides. The invention further relates to compositions and method for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based in part on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targents for the diagnosis and/or treatment (including prevention) of certain tumors (e.g., cancer) and may act as predictors of the prognosis of tumor treatment.

Sh2 Domain-Containing Peptides

View page
US Patent:
6326482, Dec 4, 2001
Filed:
Aug 9, 1999
Appl. No.:
9/367206
Inventors:
Timothy A. Stewart - San Francisco CA
Yanmei Lu - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12P 2106
C12N 506
C12N 510
C12N 120
US Classification:
536 235
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to PRO201, PRO308 or PRO309 polypeptides. The invention further relates to compositions and method for the diagnosis and treatment of neoplasfic cell growth and proliferation in mammals, including humans. The invention is based in part on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain tumors (e. g. cancer) and may act as predictors of the prognosis of tumor treatment.

Nsp Molecules

View page
US Patent:
60516909, Apr 18, 2000
Filed:
Apr 23, 1998
Appl. No.:
9/065275
Inventors:
Timothy A. Stewart - San Francisco CA
Yanmei Lu - Belmont CA
Assignee:
Genentech, Inc. - So. San Francisco CA
International Classification:
C07K 100
C07K 1600
US Classification:
530350
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs). oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to Nsp1, Nsp2 and Nsp3.

Nsp Molecules

View page
US Patent:
60514035, Apr 18, 2000
Filed:
Aug 4, 1999
Appl. No.:
9/369028
Inventors:
Timothy A. Stewart - San Francisco CA
Yanmei Lu - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12P 2106
C12N 120
C12N 114
C12N 508
C07H 2104
US Classification:
435 691
Abstract:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to Nsp1, Nsp2 and Nsp3.
Control profile
Yanmei M Lu from San Mateo, CA, age ~59 Get Report